.

Immunogen reported $373.87M in Current Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Agios Pharmaceuticals AGIO:US $ 870.01M 105.14M
Amgen AMGN:US $ 19322M 802M
Astellas Pharma 4503:JP Y 989281M 65927M
AstraZeneca AZN:LN 20.92B 1.73B
Bluebird Bio BLUE:US $ 167.46M 87.46M
Bristol Myers Squibb BMY:US $ 30186M 65M
Cerulean Pharma CERU:US $ 47.82M 7.48M
Eli Lilly And LLY:US $ 17115.2M 150.5M
Emergent Biosolutions EBS:US $ 1084.2M 16.1M
Exelixis EXEL:US $ 1851.64M 8.9M
Halozyme Therapeutics HALO:US $ 541.94M 446.75M
Heron Therapeutics HRTX:US $ 194.21M 28.38M
Immunogen IMGN:US $ 373.87M 82.84M
Intrexon XON:US $ 164.62M 9.68M
Karyopharm Therapeutics KPTI:US $ 242.45M 34.09M
Macrogenics MGNX:US $ 167.63M 50.57M
Nektar Therapeutics NKTR:US $ 665.54M 67.92M
Novartis NVS:US $ 38142M 906M
Regeneron Pharmaceuticals REGN:US $ 15529.9M 1223.9M
Seattle Genetics SGEN:US $ 2778.66M 7.4M